Latest T-knife Therapeutics News & Updates

See the latest news and media coverage for T-knife. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
T-knife Therapeutics (T-knife)

Biopharmaceutical company developing engineered T-cell cancer therapies

t-knife.com
Headquarters
San Francisco, United States
Founded year
2019
Company type
Private company
Number of employees
40–50
Industry
Pharmaceuticals

Last updated

Latest news about T-knife Therapeutics (T-knife)

In short: T-knife received authorization to initiate the Phase 1 ATLAS trial of TK-6302

Company announcements

T-knife

T-knife Therapeutics raises $110 million in Series B financing

The round is led by Fidelity Management & Research, with LSP, Qatar Investment Authority and others. Proceeds expand the scientific team, manufacturing capacity and TCR-T pipeline, including TK-8001.

Unlock all announcements with a

Media coverage

Finanznachrichten

T-knife Therapeutics Presents Preclinical Data Highlighting the Transformative Potential of the MyT Platform to Discover and Develop Next-Generation TCR Therapies to Treat ...

--Integrating a computational workflow that leverages multi-omics data with a proprietary, humanized in vivo screening platform, T-knife identified highly immunogenic solid-tumor antigens not ...

Unlock all articles with a

Never miss news about T-knife

Track T-knife and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.